Skip to content
healthcare.dev

Oxaliplatin

NDC 67184-0501, Oxaliplatin, injection, powder, lyophilized, for solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0501
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204616
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXALIPLATIN50 mg/10mL

Pharmacologic classes

Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]

Package NDCNDC-11Package
67184-0501-1671840501011 VIAL, SINGLE-DOSE in 1 CARTON (67184-0501-1) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9e47f3c-9acc-44f5-b0bd-d26fe9d35d64

Use it

Look up 67184-0501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.